Ashi Anand, CEO of IME Capital, highlights the overvaluation in smallcaps and recent correction. Despite a 20% fall, valuations remain high. Anand suggests a long-term perspective for buying opportunities. Tariffs by Trump may impact IT and pharma sectors, but exact outcomes remain uncertain.
Aequs shares slide 6% after Q4 swings to loss despite strong revenue growth
Aequs Limited shares fell 6.25% after reporting a sharp decline in Q4FY26 profitability and widened full-year losses, despite robust revenue growth. Investors are concerned over